The issue will bring together current thinking and new ideas about design and analytic methods for studies aimed at reducing health disparities from structural racism and other structural determinants of health.
health disparities
Increasing JEDI in Clinical Trials
During the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop this past September, Godwin Yung and Dooti Roy held a roundtable discussion on increasing Justice, Equity, Diversity, and Inclusion (JEDI) in clinical trials. Here, they share three takeaways from the conversation.
Flipping the Research Framework
ASA President Rob Santos illustrates how one might flip a research framework to create opportunity through a new perspective—something he sometimes does when working on policy issues as a reality check.
Brisa N. Sánchez
In a rural town along the US-Mexico border, Brisa N. Sánchez developed her love for math by making change for customers at her parents’ small grocery store. Eventually, she earned her PhD in biostatistics from Harvard and became a professor at the University of Michigan before taking on her current position as Dornsife Endowed Professor of Biostatistics at Drexel University.
Emma Benn
Emma K. T. Benn questioned why racial/ethnic minorities were not adequately represented in the field of biostatistics. Eventually, she co-founded the BEST Diversity Program, a summer program to expose under-represented minorities, economically disadvantaged students, and students with disabilities to biostatistics and its applications to cardiovascular research and public health more generally.